Real-World Evidence With Five-Year Data (2017-2022) on the use of Cladribine Tablets in Patients With Multiple Sclerosis in England: An Updated Analysis From the CLARENCE Study

被引：0

作者：

Brownlee, Wallace ^{[1
]}

Amin, Amerah ^{[2
]}

Ashton, Luke ^{[2
]}

Herbert, Alex ^{[2
]}

机构：

[1] UCL Inst Neurol, Queen Sq MS Ctr, London, England

[2] Merck Serono Ltd, Merck KGaA, Feltham, England

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1558/603

引用

页码：993 / 994

页数：2

共 50 条

[41] Evaluation of Five-year Overall Survival Rates Among 18,331 Head and Neck Cancer Patients Exposed to Different Targeted Therapies Through Real-world Data in a Case-controlled Study [J].

Baudrexl, Josefine ;

Sakkas, Andreas ;

Pietzka, Sebastian ;

Derka, Spyridoula ;

Vairaktari, Georgia ;

Scheurer, Mario ;

Schramm, Alexander ;

Wilde, Frank ;

Ebeling, Marcel .

ANTICANCER RESEARCH, 2024, 44 (03) :1247-1270

[42] No evidence of disease activity status among patients with relapsing-remitting multiple sclerosis on long-term natalizumab treatment: data from a real-world cohort in the Czech Republic [J].

Horakova, D. ;

Vaneckova, M. ;

Krasensky, J. ;

Seidl, Z. ;

van Pesch, V. ;

van Wijmeersch, B. ;

Ribbens, A. ;

van Hecke, W. ;

Freudensprung, U. ;

Hyde, R. ;

Ho, P. -R. ;

Kokic, M. ;

Uher, T. .

MULTIPLE SCLEROSIS JOURNAL, 2017, 23 :409-410

[43] LONG TERM COSTS ASSESSMENT OF ORAL THERAPIES FOR PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS BASED ON THE EVIDENCE FROM A LARGE REAL-WORLD STUDY APPLICATION TO A PORTUGUESE NATIONAL ACADEMIC HOSPITAL CENTER [J].

Lucio Rodrigues, C. ;

Silverio, N. ;

Tundia, N. .

VALUE IN HEALTH, 2022, 25 (12) :S126-S126

[44] Capturing qualitative follow up data in a "real-world" study to assess disease modifying therapy use in the multiple sclerosis population before the pandemic and after: an update from the OPTIMISE:MS pharmacovigilance study [J].

Miller, A. ;

Dobson, R. .

MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) :202-203

[45] P96 Effectiveness and safety of bimekizumab for adult patients with plaque psoriasis: an interim analysis of 2-year data from a real-world, multicentre, retrospective study [J].

Sood, Siddhartha ;

Rimke, Alexander ;

Rankin, Brian ;

Abduelmula, Abrahim ;

Georgakopoulos, Jorge ;

Maliyar, Khalad ;

Bagit, Ahmed ;

Leung, Fernejoy ;

Devani, Alim ;

Vender, Ronald ;

Yeung, Jensen ;

Prajapati, Vimal .

BRITISH JOURNAL OF DERMATOLOGY, 2024, 191

[46] Multiple Myeloma Patients Aged 40 Years and Younger Have the Same Prognosis As Older Patients in an Analysis of Real-World Evidence from Latin America: A Study of 1,316 Patients from the Gelamm Latin American Multiple Myeloma Studygroup [J].

Martinez-Cordero, Humberto ;

Pena, Camila ;

Paola Schutz, Natalia ;

Bove, Virginia ;

Villano, Fiorella ;

Osorio, Rocio ;

Chandia, Mauricio ;

Beltran, Cecilia ;

Schulz, Javier ;

Cardemil, Daniela ;

Contreras, Carolina ;

Gloria Vergara, Carmen ;

Donoso, Javiera ;

Espinoza, Marcela ;

La Rocca, Gabriel ;

Lopez-Vidal, Hernan ;

Leon, Pilar ;

Roa, Macarena ;

Rojas, Christine ;

Soto, Pablo ;

Aranda, Sandra ;

Torres, Vivianne ;

Ochoa, Paola ;

Duarte, Patricio ;

Remaggi, Guillermina ;

Yantorno, Sebastian ;

Corzo, Ariel ;

Zabaljauregui, Soledad ;

Shanley, Claudia ;

Lopresti, Sergio ;

Orlando, Sergio ;

Verri, Veronica ;

Dario Quiroga, Luis ;

Jose Garcia, Juan ;

Fernandez, Vanesa ;

Fantl, Dorotea ;

Ramirez, Jhoanna ;

Molina, Alicia ;

Papilco, Pilar ;

Mite, Alex ;

Reyes, Ines ;

Sabando Velez, Brenner ;

Ramirez Aspiazu, Francisca M. ;

Lucia Sossa, Claudia ;

Abello, Virginia ;

Idrobo, Henry ;

Saavedra, Domingo ;

Quintero, Guillermo ;

Gaviria, Lina ;

Gomez, Rigoberto .

BLOOD, 2022, 140 :7189-7191

[47] Use of Sodium-Glucose Cotransporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Atrial Fibrillation and Heart Failure From 2021 to 2022: An Analysis of Real-World Data [J].

Alonso, Alvaro ;

Morris, Alanna A. ;

Naimi, Ashley I. ;

Alam, Aniqa B. ;

Li, Linzi ;

Subramanya, Vinita ;

Chen, Lin Yee ;

Lutsey, Pamela L. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (06)

[48] Real-world use of deucravacitinib in high-impact areas: interim data from a 5-year, multicenter, prospective study in patients with moderate to severe plaque psoriasis in Germany (DELPHIN) [J].

von Kiedrowski, Ralph ;

Augustin, Matthias ;

Sbornik, Martin ;

Schaekel, Knut ;

Hockmann, Johannes ;

Korge, Bernhard ;

Ertner, Konstantin ;

Quack, Christine ;

Mortazawi, Dariusch ;

Medina, Manuel Cer villa ;

Mueller, Alice ;

Kaegebein, Danny ;

Makki, Miriam ;

Vaz, Luis ;

Bluhmki, Tobias ;

Ghoreschi, Kamran .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025, 23

[49] Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice [J].

Mohty, Mohamad ;

Terpos, Evangelos ;

Mateos, Maria-Victoria ;

Palumbo, Antonio ;

Lejniece, Sandra ;

Beksac, Meral ;

Bekadja, Mohamed Amine ;

Legiec, Wojciech ;

Dimopoulos, Meletios ;

Stankovic, Svetlana ;

Duran, Maria Soledad ;

De Stefano, Valerio ;

Corso, Alessandro ;

Kochkareva, Yulia ;

Laane, Edward ;

Berthou, Christian ;

Salwender, Hans-Juergen ;

Masliak, Zvenyslava ;

Peceliunas, Valdas ;

Willenbacher, Wolfgang ;

Da Silva, Joao ;

Louw, Vernon ;

Nemet, Damir ;

Borbenyi, Zita ;

Abadi, Uri ;

Pedersen, Robert Schou ;

Cernelc, Peter ;

Potamianou, Anna ;

Couturier, Catherine ;

Olie, Robert ;

Feys, Caroline ;

Thoret-Bauchet, Florence ;

Boccadoro, Mario .

BLOOD, 2015, 126 (23)

[50] A cost-effectiveness analysis using real-world data from the MSBase registry: comparing natalizumab to fingolimod in patients with inadequate response to diseasemodifying therapies in relapsing-remitting multiple sclerosis (RRMS) in Scotland [J].

Herring, William ;

Zhang, Yuanhui ;

Pearson, Isobel ;

Tempest, Michael ;

Freudensprung, Ulrich ;

Acosta, Carlos ;

Hyde, Robert ;

Spelman, Timothy ;

Butzkueven, Helmut .

NEUROLOGY, 2018, 90

← 1 2 3 4 5 →